NASDAQ: BNGO
Bionano Genomics Inc Stock Forecast, Predictions & Price Target

Analyst price target for BNGO

Based on 1 analyst offering 12 month price targets for Bionano Genomics Inc

Min Forecast
$1.00+726.45%
Avg Forecast
$1.00+726.45%
Max Forecast
$1.00+726.45%

Should I buy or sell BNGO stock?

Based on 1 analyst offering ratings for Bionano Genomics Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BNGO stock forecasts and price targets.

BNGO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-28

1 of 1

Forecast return on equity

Is BNGO forecast to generate an efficient return?

Company
-77.22%
Industry
16.73%
Market
230.57%
BNGO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BNGO forecast to generate an efficient return on assets?

Company
-43.2%
Industry
11.89%
BNGO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BNGO earnings per share forecast

What is BNGO's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.51
Avg 2 year Forecast
-$0.37

BNGO vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
BNGO$0.12$1.00+726.45%Hold
EKSO$0.64$5.50+754.04%Strong Buy
LUCY$5.85N/AN/A
POAI$1.47$3.00+104.08%Buy
MHUA$0.32N/AN/A

Bionano Genomics Stock Forecast FAQ

Is Bionano Genomics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BNGO) stock is to Hold BNGO stock.

Out of 1 analyst, 0 (0%) are recommending BNGO as a Strong Buy, 0 (0%) are recommending BNGO as a Buy, 1 (100%) are recommending BNGO as a Hold, 0 (0%) are recommending BNGO as a Sell, and 0 (0%) are recommending BNGO as a Strong Sell.

If you're new to stock investing, here's how to buy Bionano Genomics stock.

What is BNGO's earnings growth forecast for 2025-2026?

(NASDAQ: BNGO) Bionano Genomics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 71.21%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 59.2%.

Bionano Genomics's earnings in 2025 is -$135,783,000.On average, 1 Wall Street analyst forecast BNGO's earnings for 2025 to be -$52,016,545, with the lowest BNGO earnings forecast at -$52,016,545, and the highest BNGO earnings forecast at -$52,016,545.

In 2026, BNGO is forecast to generate -$37,737,493 in earnings, with the lowest earnings forecast at -$37,737,493 and the highest earnings forecast at -$37,737,493.

What is BNGO's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: BNGO) forecast ROE is -77.22%, which is considered weak.

What is BNGO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BNGO price target, the average BNGO price target is $1.00, with the highest BNGO stock price forecast at $1.00 and the lowest BNGO stock price forecast at $1.00.

The Wall Street analyst predicted that Bionano Genomics's share price could reach $1.00 by Aug 28, 2025. The average Bionano Genomics stock price prediction forecasts a potential upside of 726.45% from the current BNGO share price of $0.12.

What is BNGO's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: BNGO) Bionano Genomics's current Earnings Per Share (EPS) is -$2.32. On average, analysts forecast that BNGO's EPS will be -$0.51 for 2025, with the lowest EPS forecast at -$0.51, and the highest EPS forecast at -$0.51. In 2026, BNGO's EPS is forecast to hit -$0.37 (min: -$0.37, max: -$0.37).

What is BNGO's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: BNGO) forecast ROA is -43.2%, which is lower than the forecast US Medical Instruments & Supplies industry average of 11.89%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.